1151PPhase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors. (18th September 2017) - Hosono, A.; Yoshikawa, T.; Tsuchiya, N.; Fujinami, N.; Saito, K.; Mizuno, S.; Nakatsura, T.